Cell-matrix mechanics and pattern formation in inflammatory cardiovascular calcification

Heart

Volumn 102, Issue 21, 2016, Pages 1710-1715

  Hsu, Jeffrey J ^a   Lim, Jina ^b   Tintut, Yin ^a,b   Demer, Linda L ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c University of California   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 CARBOXYGLUTAMIC ACID; BONE MORPHOGENETIC PROTEIN; CYTOKINE; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; AUTACOID;

AORTA VALVE DISEASE; ARTERIAL STIFFNESS; ARTERY CALCIFICATION; ARTERY RUPTURE; ARTICLE; BIOMECHANICS; BONE MATRIX; BONE MINERALIZATION; CALCIFICATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL DIFFERENTIATION; CELL STRUCTURE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; EXTRACELLULAR MATRIX; HUMAN; INFLAMMATORY CARDIOVASCULAR CALCIFICATION; NONHUMAN; PATTERN FORMATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGENITOR CELL LINE; PROTEIN EXPRESSION; SHEAR STRESS; SMOOTH MUSCLE CELL; SURFACE AREA; ANIMAL; AORTIC VALVE; AORTIC VALVE STENOSIS; ARTERY; ATHEROSCLEROSIS; BLOOD VESSEL CALCIFICATION; CALCINOSIS; CELL ADHESION; ELASTICITY; INFLAMMATION; MECHANICAL STRESS; MECHANOTRANSDUCTION; METABOLISM; PATHOLOGY; PHYSIOLOGICAL FEEDBACK; TUMOR MICROENVIRONMENT;

ANIMALS; AORTIC VALVE; AORTIC VALVE STENOSIS; ARTERIES; ATHEROSCLEROSIS; BIOMECHANICAL PHENOMENA; CALCINOSIS; CELL ADHESION; CELLULAR MICROENVIRONMENT; CYTOKINES; ELASTICITY; EXTRACELLULAR MATRIX; FEEDBACK, PHYSIOLOGICAL; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MECHANOTRANSDUCTION, CELLULAR; STRESS, MECHANICAL; VASCULAR CALCIFICATION;

EID: 84978828733     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2016-309667     Document Type: Article

References (71)

1. Davies P, Bucky NL. Tomography of calcified aortic and mitral valves. Br Heart J 1959;21:17-22.
2. Demer LL, Tintut Y. Vascular calcification: pathobiology of a multifaceted disease. Circulation 2008;117:2938-48.
3. Allison MA, Criqui MH, Wright CM. Patterns and risk factors for systemic calcified atherosclerosis. Arterioscler Thromb Vasc Biol 2004;24:331-6.
4. Gepner AD, Young R, Delaney JA, et al. Comparison of coronary artery calcium presence, carotid plaque presence, and carotid intima-media thickness for cardiovascular disease prediction in the Multi-Ethnic Study of Atherosclerosis. Circ Cardiovasc Imaging 2015;8:pii: e002262.
5. Polonsky TS, McClelland RL, Jorgensen NW, et al. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA 2010;303:1610-16.
6. Demer LL, Tintut Y. Inflammatory, metabolic, and genetic mechanisms of vascular calcification. Arterioscler Thromb Vasc Biol 2014;34:715-23.
7. Shanahan CM, Crouthamel MH, Kapustin A, et al. Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ Res 2011;109:697-711.
8. Hoshino T, Chow LA, Hsu JJ, et al. Mechanical stress analysis of a rigid inclusion in distensible material: a model of atherosclerotic calcification and plaque vulnerability. Am J Physiol Heart Circ Physiol 2009;297:H802-10.
9. Abedin M, Tintut Y, Demer LL. Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol 2004;24:1161-70.
10. Joshi NV, Vesey AT, Williams MC, et al. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial. Lancet Lond Engl 2014;383:705-13.
11. Dweck MR, Jenkins WSA, Vesey AT, et al. 18F-sodium fluoride uptake is a marker of active calcification and disease progression in patients with aortic stenosis. Circ Cardiovasc Imaging 2014;7:371-8.
12. Lindroos M, Kupari M, Heikkilä J, et al. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol 1993;21:1220-5.
13. Otto CM, Lind BK, Kitzman DW, et al. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999;341:142-7.
14. Mohler ER, Gannon F, Reynolds C, et al. Bone formation and inflammation in cardiac valves. Circulation 2001;103:1522-8.
15. Rajamannan NM, Subramaniam M, Rickard D, et al. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation 2003;107:2181-4.
16. Boström K, Watson KE, Horn S, et al. Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest 1993;91:1800-9.
17. Tintut Y, Parhami F, Boström K, et al. cAMP stimulates osteoblast-like differentiation of calcifying vascular cells. Potential signaling pathway for vascular calcification. J Biol Chem 1998;273:7547-53.
18. Daoud AS, Frank AS, Jarmolych J, et al. Ultrastructural and elemental analysis of calcification of advanced swine aortic atherosclerosis. Exp Mol Pathol 1985;43:337-47.
19. Reid JD, Andersen ME. Medial calcification (whitlockite) in the aorta. Atherosclerosis 1993;101:213-24.
20. Cottignoli V, Relucenti M, Agrosí G, et al. Biological niches within human calcified aortic valves: towards understanding of the pathological biomineralization process. BioMed Res Int 2015;2015:542687.
21. Hunt JL, Fairman R, Mitchell ME, et al. Bone formation in carotid plaques: a clinicopathological study. Stroke J Cereb Circ 2002;33:1214-19.
22. Davaine J-M, Quillard T, Chatelais M, et al. Bone like arterial calcification in femoral atherosclerotic lesions: prevalence and role of osteoprotegerin and pericytes. Eur J Vasc Endovasc Surg Off J Eur Soc Vasc Surg 2016;51:259-67.
23. Hutcheson JD, Goettsch C, Bertazzo S, et al. Genesis and growth of extracellular-vesicle-derived microcalcification in atherosclerotic plaques. Nat Mater 2016;15:335-43.
24. New SEP, Goettsch C, Aikawa M, et al. Macrophage-derived matrix vesicles: an alternative novel mechanism for microcalcification in atherosclerotic plaques. Circ Res 2013;113:72-7.
25. Kapustin AN, Chatrou MLL, Drozdov I, et al. Vascular smooth muscle cell calcification is mediated by regulated exosome secretion. Circ Res 2015;116:1312-23.
26. Bertazzo S, Gentleman E, Cloyd KL, et al. Nano-Analytical electron microscopy reveals fundamental insights into human cardiovascular tissue calcification. Nat Mater 2013;12:576-83.
27. Gondrie MJA, van der Graaf Y, Jacobs PC, et al. The association of incidentally detected heart valve calcification with future cardiovascular events. Eur Radiol 2011;21:963-73.
28. Rennenberg RJMW, Kessels AGH, Schurgers LJ, et al. Vascular calcifications as a marker of increased cardiovascular risk: a meta-Analysis. Vasc Health Risk Manag 2009;5:185-97.
29. Bruunsgaard H, Skinhøj P, Pedersen AN, et al. Ageing, tumour necrosis factor-Alpha (TNF-Alpha) and atherosclerosis. Clin Exp Immunol 2000;121:255-60.
30. Swierszcz J, Dubiel JS, Krzysiek J, et al. One-year observation of inflammatory markers in patients with aortic valve stenosis. J Heart Valve Dis 2011;20:639-49.
31. Al-Aly Z, Shao JS, Lai CF, et al. Aortic Msx2-Wnt calcification cascade is regulated by TNF-Alpha-dependent signals in diabetic Ldlr-/-mice. Arterioscler Thromb Vasc Biol 2007;27:2589-96.
32. Li X, Lim J, Lu J, et al. Protective role of smad6 in inflammation-induced valvular cell calcification. J Cell Biochem 2015;116:2354-64.
33. Sorokin L. The impact of the extracellular matrix on inflammation. Nat Rev Immunol 2010;10:712-23.
34. Parhami F, Morrow AD, Balucan J, et al. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol 1997;17:680-7.
35. Yu Z, Seya K, Daitoku K, et al. Tumor necrosis factor-A accelerates the calcification of human aortic valve interstitial cells obtained from patients with calcific aortic valve stenosis via the BMP2-Dlx5 pathway. J Pharmacol Exp Ther 2011;337:16-23.
36. Aikawa E, Nahrendorf M, Figueiredo J-L, et al. Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation 2007;116:2841-50.
37. Shroff RC, McNair R, Skepper JN, et al. Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification. J Am Soc Nephrol 2010;21:103-12.
38. Mazzone A, Epistolato MC, De Caterina R, et al. Neoangiogenesis, T-lymphocyte infiltration, and heat shock protein-60 are biological hallmarks of an immunomediated inflammatory process in end-stage calcified aortic valve stenosis. J Am Coll Cardiol 2004;43:1670-6.
39. Lim J, Ehsanipour A, Hsu JJ, et al. Inflammation drives retraction, stiffening and nodule formation via cytoskeletal machinery in a 3-dimensional culture model of aortic stenosis. Am J Pathol In Press.
40. Watson KE, Parhami F, Shin V, et al. Fibronectin and collagen I matrixes promote calcification of vascular cells in vitro, whereas collagen IV matrix is inhibitory. Arterioscler Thromb Vasc Biol 1998;18:1964-71.
41. Fayet C, Bendeck MP, Gotlieb AI. Cardiac valve interstitial cells secrete fibronectin and form fibrillar adhesions in response to injury. Cardiovasc Pathol Off J Soc Cardiovasc Pathol 2007;16:203-11.
42. Fondard O, Detaint D, Iung B, et al. Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors. Eur Heart J 2005;26:1333-41.
43. Kaden JJ, Dempfle C-E, Grobholz R, et al. Inflammatory regulation of extracellular matrix remodeling in calcific aortic valve stenosis. Cardiovasc Pathol Off J Soc Cardiovasc Pathol 2005;14:80-7.
44. Van der Hoek YY, Sangrar W, Coté GP, et al. Binding of recombinant apolipoprotein (a) to extracellular matrix proteins. Arterioscler Thromb J Vasc Biol Am Heart Assoc 1994;14:1792-8.
45. O'Brien KD, Olin KL, Alpers CE, et al. Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: colocalization of biglycan with apolipoproteins. Circulation 1998;98:519-27.
46. Ingber DE. Cellular mechanotransduction: putting all the pieces together again. FASEB J Off Publ Fed Am Soc Exp Biol 2006;20:811-27.
47. Yip CY, Chen JH, Zhao R, et al. Calcification by valve interstitial cells is regulated by the stiffness of the extracellular matrix. Arterioscler Thromb Vasc Biol 2009;29:936-42.
48. Engler AJ, Sen S, Sweeney HL, et al. Matrix elasticity directs stem cell lineage specification. Cell 2006;126:677-89.
49. Swift J, Ivanovska IL, Buxboim A, et al. Nuclear lamin-A scales with tissue stiffness and enhances matrix-directed differentiation. Science 2013;341:1240104.
50. Wang H, Haeger SM, Kloxin AM, et al. Redirecting valvular myofibroblasts into dormant fibroblasts through light-mediated reduction in substrate modulus. PLoS ONE 2012;7:e39969.
51. Wipff P-J, Hinz B. Integrins and the activation of latent transforming growth factor beta1-An intimate relationship. Eur J Cell Biol 2008;87:601-15.
52. Watson KE, Boström K, Ravindranath R, et al. TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J Clin Invest 1994;93:2106-13.
53. Rodriguez KJ, Masters KS. Regulation of valvular interstitial cell calcification by components of the extracellular matrix. J Biomed Mater Res A 2009;90:1043-53.
54. Simmons CA, Grant GR, Manduchi E, et al. Spatial heterogeneity of endothelial phenotypes correlates with side-specific vulnerability to calcification in normal porcine aortic valves. Circ Res 2005;96:792-9.
55. Sucosky P, Balachandran K, Elhammali A, et al. Altered shear stress stimulates upregulation of endothelial VCAM-1 and ICAM-1 in a BMP-4-And TGF-beta1-dependent pathway. Arterioscler Thromb Vasc Biol 2009;29:254-60.
56. Weiler M, Yap CH, Balachandran K, et al. Regional analysis of dynamic deformation characteristics of native aortic valve leaflets. J Biomech 2011;44:1459-65.
57. Fisher CI, Chen J, Merryman WD. Calcific nodule morphogenesis by heart valve interstitial cells is strain dependent. Biomech Model Mechanobiol 2013;12:5-17.
58. Hutcheson JD, Venkataraman R, Baudenbacher FJ, et al. Intracellular Ca(2+) accumulation is strain-dependent and correlates with apoptosis in aortic valve fibroblasts. J Biomech 2012;45:888-94.
59. Garfinkel A, Tintut Y, Petrasek D, et al. Pattern formation by vascular mesenchymal cells. Proc Natl Acad Sci USA 2004;101:9247-50.
60. Cheng H, Reddy A, Sage A, et al. Focal high cell density generates a gradient of patterns in self-organizing vascular mesenchymal cells. J Vasc Res 2012;49:441-6.
61. Yao Y, Nowak S, Yochelis A, et al. Matrix GLA protein, an inhibitory morphogen in pulmonary vascular development. J Biol Chem 2007;282:30131-42.
62. Guo Y, Chen T-H, Zeng X, et al. Branching patterns emerge in a mathematical model of the dynamics of lung development. J Physiol (Lond) 2014;592:313-24.
63. Chen T-H, Guo C, Zhao X, et al. Patterns of periodic holes created by increased cell motility. Interface Focus 2012;2:457-64.
64. Chen T-H, Hsu JJ, Zhao X, et al. Left-right symmetry breaking in tissue morphogenesis via cytoskeletal mechanics. Circ Res 2012;110:551-9.
65. Chen T-H, Zhu X, Pan L, et al. Directing tissue morphogenesis via self-Assembly of vascular mesenchymal cells. Biomaterials 2012;33:9019-26.
66. Ehara S, Kobayashi Y, Yoshiyama M, et al. Spotty calcification typifies the culprit plaque in patients with acute myocardial infarction: an intravascular ultrasound study. Circulation 2004;110:3424-9.
67. Kronenberg HM. Developmental regulation of the growth plate. Nature 2003;423:332-6.
68. Hinz B. The extracellular matrix and transforming growth factor-β1: Tale of a strained relationship. Matrix Biol J Int Soc Matrix Biol 2015;47:54-65.
69. Chen J-H, Chen WLK, Sider KL, et al. β-catenin mediates mechanically regulated, transforming growth factor-β1-induced myofibroblast differentiation of aortic valve interstitial cells. Arterioscler Thromb Vasc Biol 2011;31:590-7.
70. Nakasaki M, Hwang Y, Xie Y, et al. The matrix protein Fibulin-5 is at the interface of tissue stiffness and inflammation in fibrosis. Nat Commun 2015;6:8574.
71. Paccou J, Renard C, Liabeuf S, et al. Coronary and abdominal aorta calcification in rheumatoid arthritis: relationships with traditional cardiovascular risk factors, disease characteristics, and concomitant treatments. J Rheumatol 2014;41:2137-44.